Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05459571
Title Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell Lymphoma (ZUMA-24)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kite, A Gilead Company

diffuse large B-cell lymphoma

follicular lymphoma

B-cell lymphoma

primary mediastinal B-cell lymphoma


axicabtagene ciloleucel + Cyclophosphamide + Dexamethasone + Fludarabine

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.